SmartCella Holding AB
@smartcella.com
SmartCella is a global drug delivery company providing first-in-class delivery platforms for targeted therapies, including the main technology, the FDA 510(k)-cleared Extroducer® for localized endovascular delivery to hard-to-reach organs and tissues, and a proprietary stem cell platform for the delivery of mRNA therapeutics.
SmartCella Holding AB's Company Logos
SmartCella Holding AB's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#F0411F
Pomegranate
240, 65, 31
10, 87, 53
0, 73, 87, 6
#FBFAF9
Pampas
251, 250, 249
30, 20, 98
0, 0, 1, 2
#2C2C2C
Mine Shaft
44, 44, 44
0, 0, 17
0, 0, 0, 83
About SmartCella Holding AB
SmartCella is a world-leading biotechnology company based in Tullinge, Sweden, founded in 2014. They are at the forefront of pioneering targeted therapies by combining innovative delivery platforms with cutting-edge cell and gene therapies.
The company comprises three core units: SmartWise, which offers the FDA-approved Extroducer for direct tissue or organ infusion, SmartCella Solutions focusing on mRNA therapies for precise delivery within organs, and Procella, specializing in stem cell therapy development and manufacturing.
SmartCella collaborates with AstraZeneca on cardiac stem cell therapy and has a growing pipeline of stem cell treatments. Their team of around 60 employees, consisting of diverse nationalities, including scientists and researchers, work towards their vision of transforming lives through targeted therapies. SmartCella, being privately owned and funded, aims to pioneer new treatment paradigms and unlock the full potential of targeted therapies.
Company type
Privately Held
Year founded
2014
Company size
11-50 employees
